Cyclacel Stock Future Price Prediction


USD 1.46  0.14  10.61%   

Cyclacel Pharmaceuti stock price prediction is an act of determining the future value of Cyclacel Pharmaceuti shares using few different conventional methods such as EPS estimation, analyst consensus, or fundamental intrinsic valuation. The successful prediction of Cyclacel Pharmaceuti's future price could yield a significant profit. Please, note that this module is not intended to be used solely to calculate an intrinsic value of Cyclacel Pharmaceuti and does not consider all of the tangible or intangible factors available from Cyclacel Pharmaceuti's fundamental data. We analyze noise-free headlines and recent hype associated with Cyclacel Pharmaceuti, which may create opportunities for some arbitrage if properly timed.
Continue to Cyclacel Pharmaceuti Basic Forecasting Models to cross-verify your projections.
It is a matter of debate whether stock price prediction based on information in financial news can generate a strong buy or sell signal. We use our internally-built news screening methodology to estimate the value of Cyclacel Pharmaceuti based on different types of headlines from major news networks to social media. The Cyclacel stock price prediction module provides an analysis of price elasticity to changes in media outlook on Cyclacel Pharmaceuti over a specific investment horizon.Using Cyclacel Pharmaceuti hype-based prediction, you can estimate the value of Cyclacel Pharmaceuti from the perspective of Cyclacel Pharmaceuti response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Cyclacel Pharmaceuti using Cyclacel Pharmaceuti's stock options and short interest. It helps to benchmark the overall future attitude of investors towards Cyclacel using crowd psychology based on the activity and movement of Cyclacel Pharmaceuti's stock price.

Cyclacel Pharmaceuti Implied Volatility

Cyclacel Pharmaceuti's implied volatility exposes the market's sentiment of Cyclacel Pharmaceuti stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Cyclacel Pharmaceuti's implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Cyclacel Pharmaceuti stock will not fluctuate a lot when Cyclacel Pharmaceuti's options are near their expiration.
This module is based on analyzing investor sentiment around taking a position in Cyclacel Pharmaceuti. This speculative approach is based exclusively on the idea that markets are driven by emotions such as investor fear and greed. The fear of missing out, i.e., FOMO, can cause potential investors in Cyclacel Pharmaceuti to buy its stock at a price that has no basis in reality. In that case, they are not buying Cyclacel because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.

Cyclacel Pharmaceuti after-hype prediction price

  $ 1.43  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Sophisticated investors, who have witnessed many market ups and downs, frequently view the market will even out over time. This tendency of Cyclacel Pharmaceuti's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy. Please use the tools below to analyze the current value of Cyclacel Pharmaceuti in the context of predictive analytics.
LowReal ValueHigh
4 Analysts
LowTarget PriceHigh
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Cyclacel Pharmaceuti. Your research has to be compared to or analyzed against Cyclacel Pharmaceuti's peers to derive any actionable benefits. When done correctly, Cyclacel Pharmaceuti's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy towards taking a position in Cyclacel Pharmaceuti.

Cyclacel Pharmaceuti After-Hype Price Prediction Density Analysis

As far as predicting the price of Cyclacel Pharmaceuti at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Cyclacel Pharmaceuti or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Cyclacel Pharmaceuti, with the unreliable approximations that try to describe financial returns.
   Next price density   
       Expected price to next headline  

Cyclacel Pharmaceuti Estimiated After-Hype Price Volatility

In the context of predicting Cyclacel Pharmaceuti's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Cyclacel Pharmaceuti's historical news coverage. Cyclacel Pharmaceuti's after-hype downside and upside margins for the prediction period are 0.07 and 8.59, respectively. We have considered Cyclacel Pharmaceuti's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value 1.46
After-hype Price
Cyclacel Pharmaceuti is unstable asset. Analysis and calculation of next after-hype price of Cyclacel Pharmaceuti is based on 3 months time horizon.

Cyclacel Pharmaceuti Stock Price Prediction Analysis

Have you ever been surprised when a price of a company such as Cyclacel Pharmaceuti is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Cyclacel Pharmaceuti backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Cyclacel Pharmaceuti, there might be something going there, and it might present an excellent short sale opportunity.
Expected ReturnPeriod VolatilityHype ElasticityRelated ElasticityNews DensityRelated DensityExpected Hype
 0.63  7.22   0.03   0.21  5 Events / Month3 Events / MonthIn about 5 days
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility

Cyclacel Pharmaceuti Hype Timeline

Cyclacel Pharmaceuti is currently traded for 1.46. The entity has historical hype elasticity of -0.03 and average elasticity to hype of competition of 0.21. Cyclacel is forecasted to decline in value after the next headline with the price expected to drop to 1.43. The average volatility of media hype impact on the company price is over 100%. The price decrease on the next newsis expected to be -2.05% whereas the daily expected return is currently at 0.63%. The volatility of related hype on Cyclacel Pharmaceuti is about 2148.81% with expected price after next announcement by competition of 1.67. About 41.0% of the company shares are held by institutions such as insurance companies. The company has price-to-book (P/B) ratio of 0.25. Some equities with similar Price to Book (P/B) outperform the market in the long run. Cyclacel Pharmaceuti recorded a loss per share of 3.42. The entity had not issued any dividends in recent years. The firm had 1-20 split on the 15th of April 2020. Given the investment horizon of 90 days the next forecasted press release will be in about 5 days.
Continue to Cyclacel Pharmaceuti Basic Forecasting Models to cross-verify your projections.

Cyclacel Pharmaceuti Related Hype Analysis

Having access to credible news sources related to Cyclacel Pharmaceuti's direct competition is more important than ever and may enhance your ability to predict Cyclacel Pharmaceuti's future price movements. Getting to know how Cyclacel Pharmaceuti rivals react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Cyclacel Pharmaceuti may potentially react to the hype associated with one of its peers.

Cyclacel Pharmaceuti Additional Predictive Modules

Most predictive techniques to examine Cyclacel price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Cyclacel using various technical indicators. When you analyze Cyclacel charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Cyclacel Pharmaceuti Predictive Indicators

The successful prediction of Cyclacel Pharmaceuti stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Cyclacel Pharmaceuti, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Cyclacel Pharmaceuti based on analysis of Cyclacel Pharmaceuti hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Cyclacel Pharmaceuti's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Cyclacel Pharmaceuti's related companies.

Story Coverage note for Cyclacel Pharmaceuti

The number of cover stories for Cyclacel Pharmaceuti depends on current market conditions and Cyclacel Pharmaceuti's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Cyclacel Pharmaceuti is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Cyclacel Pharmaceuti's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

Cyclacel Pharmaceuti Short Properties

Cyclacel Pharmaceuti's future price predictability will typically decrease when Cyclacel Pharmaceuti's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Cyclacel Pharmaceuti often depends not only on the future outlook of the potential Cyclacel Pharmaceuti's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Cyclacel Pharmaceuti's indicators that are reflective of the short sentiment are summarized in the table below.
Shares Percent Shares Out5.84%
Short Percent Of Float6.04%
Float Shares7.7M
Shares Short Prior Month249.53k
Average Daily Volume Last 10 Day170.13k
Average Daily Volume In Three Month1.05M
Date Short Interest15th of July 2022
Continue to Cyclacel Pharmaceuti Basic Forecasting Models to cross-verify your projections. Note that the Cyclacel Pharmaceuti information on this page should be used as a complementary analysis to other Cyclacel Pharmaceuti's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Bond Directory module to find actively traded corporate debentures issued by US companies.

Complementary Tools for Cyclacel Stock analysis

When running Cyclacel Pharmaceuti price analysis, check to measure Cyclacel Pharmaceuti's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cyclacel Pharmaceuti is operating at the current time. Most of Cyclacel Pharmaceuti's value examination focuses on studying past and present price action to predict the probability of Cyclacel Pharmaceuti's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Cyclacel Pharmaceuti's price. Additionally, you may evaluate how the addition of Cyclacel Pharmaceuti to your portfolios can decrease your overall portfolio volatility.
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Is Cyclacel Pharmaceuti's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cyclacel Pharmaceuti. If investors know Cyclacel will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cyclacel Pharmaceuti listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Cyclacel Pharmaceuti is measured differently than its book value, which is the value of Cyclacel that is recorded on the company's balance sheet. Investors also form their own opinion of Cyclacel Pharmaceuti's value that differs from its market value or its book value, called intrinsic value, which is Cyclacel Pharmaceuti's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cyclacel Pharmaceuti's market value can be influenced by many factors that don't directly affect Cyclacel Pharmaceuti's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Cyclacel Pharmaceuti's value and its price as these two are different measures arrived at by different means. Investors typically determine Cyclacel Pharmaceuti value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cyclacel Pharmaceuti's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.